Relating to the use of epinephrine auto-injectors on public school and open-enrollment charter school campuses and at or in transit to or from off-campus school events.
Relating to policies and training regarding the use of epinephrine auto-injectors by school districts and open-enrollment charter schools; providing immunity.
Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
Relating to the administration of epinephrine medication by public and private schools.
Relating to policies and training regarding the use of epinephrine auto-injectors by public institutions of higher education; providing immunity.
Relating to policies and training regarding the use of epinephrine auto-injectors by public institutions of higher education; providing immunity.
Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
Relating to the use of an epinephrine delivery system by certain entities.